Bariatric Surgery Outperforms GLP-1 Medications for Long-Term Diabetes and Obesity Outcomes
TL;DR Summary
This study compares the macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity, highlighting the potential benefits and data sharing protocols, with references to related research and long-term outcomes.
- Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity Nature
- Bariatric surgery for weight loss shows greater long-term benefits than GLP-1 medicines Medical Xpress
- Fat jabs vs weight loss ops - the best way to lose weight, live longer and slash your risk of deadly diseases revealed The Sun
- Cleveland Clinic Study Finds Bariatric Surgery Offers Superior Long-Term Benefits Over GLP-1 Medications Bioengineer.org
- Bariatric Surgery Linked to New-Onset Obesity-Related Comorbidities Bioengineer.org
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
11 min
vs 12 min read
Condensed
98%
2,296 → 37 words
Want the full story? Read the original article
Read on Nature